About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On May 16, PhRMA participated in Financial Times’ US Pharma and Biotech Summit. Robby Zirkelbach, PhRMA’s Chief Public Affairs Officer and Head of Strategic Initiatives, joined a panel discussion titled, “The Impact of a Pivotal Presidential Election on the Biopharma Industry.” During the conversation, Zirkelbach discussed the future of health care policy, emphasizing key Inflation Reduction Act and pharmacy benefit manager (PBM) reforms that will better protect patient access.
When:
May 16, 2024, at 4:30 PM ET
Speakers:
- Eric Gascho, Senior Vice President, Policy and Government Affairs, National Health Council
- Terri Stewart, Senior Vice President, Head of Global Healthcare Government and Public Affairs, EMD Serono
- Robby Zirkelbach, Chief Public Affairs Officer and Head of Strategic Initiatives, PhRMA
- Oliver Barnes, US Pharmaceutical and Biotech Correspondent, Financial Times (Moderator)
Event
Cost and Value
Financial Times: US Pharma and Biotech Summit
Financial Times: US Pharma and Biotech Summit image